First-in-Human Percutaneous Transcatheter Tricuspid Valve Replacement With a Novel Valve

The surgical intervention to treat isolated severe tricuspid regurgitation (TR) is challenging due to the severe TR patients’ high-risk profile, hence associated with a high complication rate. Herein, we describe a first-in-human percutaneous deployment of a novel transcatheter prosthetic xenograft...

Full description

Saved in:
Bibliographic Details
Published in:JACC. Case reports 2021-08, Vol.3 (10), p.1281-1286
Main Authors: Vaturi, Mordehay, Vaknin-Assa, Hana, Shapira, Yaron, Perl, Leor, Levi, Amos, Koren, Arnon, Kornowski, Ran
Format: Article
Language:English
Subjects:
Case Report
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The surgical intervention to treat isolated severe tricuspid regurgitation (TR) is challenging due to the severe TR patients’ high-risk profile, hence associated with a high complication rate. Herein, we describe a first-in-human percutaneous deployment of a novel transcatheter prosthetic xenograft valve to treat severe TR. ( Level of Difficulty: Advanced. )
ISSN:2666-0849
2666-0849
DOI:10.1016/j.jaccas.2021.06.014